Valganciclovir

Paul A. Pham, Pharm.D., Kathryn Dzintars, Pharm.D., BCPS, Alice Jenh Hsu, Pharm.D.
Valganciclovir is a topic covered in the Johns Hopkins ABX Guide.

To view the entire topic, please or purchase a subscription.

Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:

Pediatrics Central

-- The first section of this topic is shown below --

INDICATIONS

FDA

  • Treatment of CMV retinitis (AIDS).
  • Prevention of CMV disease: renal, cardiac and kidney-pancreas transplant patients at high risk for CMV disease (e.g., donor positive, recipient negative).
    • Not indicated in liver transplant patients.

NON-FDA APPROVED USES

  • Prevention of disseminated CMV disease of the contralateral eye in patients treated with intraocular ganciclovir implant (no longer manufactured).

-- To view the remaining sections of this topic, please or purchase a subscription --

Last updated: January 6, 2016